Literature DB >> 1314191

Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers.

T Schaberg1, H Haller, M Rau, D Kaiser, M Fassbender, H Lode.   

Abstract

This study was designed to investigate the effects of the platelet-activating factor (PAF) on the superoxide anion production (O2.) of human alveolar macrophages (AM) from nonsmoking (n = 18) and smoking (n = 30) subjects. Freshly isolated cells were stimulated with (PAF) or with a phorbol ester (phorbol 12-myristate 13 acetate (PMA)). Stimulation with PAF led to a dose-dependent increase of O2. production by AM in both groups. The median effective dose (EC50) for PAF action on O2. production of smoker AM was 0.5 x 10(-8) M, compared to nonsmoker AM with an EC50 of 1.0 x 10(-7) M. This effect of PAF was blockable by the PAF-antagonist WEB 2086 in a dose-dependent manner. Comparison of the relative increase of O2. production after PAF-stimulation showed that smoker cells were significantly more sensitive to PAF than nonsmoker cells (p less than 0.01). In contrast to the findings with PAF, the relative increase of O2. production after PMA-stimulation showed no differences between smoker and nonsmoker AM. Our data suggest that AM from smoking subjects are more sensitive to PAF than AM from nonsmokers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314191

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

Review 1.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

Review 2.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

4.  Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease.

Authors:  Ahmed Nadeem; Hanumanthrao Guru Raj; Sunil Kumar Chhabra
Journal:  Inflammation       Date:  2005-02       Impact factor: 4.092

5.  Effects of shear stresses and antioxidant concentrations on the production of reactive oxygen species in lung cancer cells.

Authors:  Kai-Yin Lo; Yun Zhu; Hsieh-Fu Tsai; Yung-Shin Sun
Journal:  Biomicrofluidics       Date:  2013-11-26       Impact factor: 2.800

6.  Effect of an inhaled glucocorticoid on reactive oxygen species production by bronchoalveolar lavage cells from smoking COPD patients.

Authors:  G T Verhoeven; A J Wijkhuijs; H Hooijkaas; H C Hoogsteden; W Sluiter
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

Review 7.  COPD: balancing oxidants and antioxidants.

Authors:  Bernard M Fischer; Judith A Voynow; Andrew J Ghio
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-02

Review 8.  N-acetylcysteine in COPD: why, how, and when?

Authors:  Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2016-02-03

Review 9.  Cigarette Smoke Particle-Induced Lung Injury and Iron Homeostasis.

Authors:  Andrew J Ghio; Elizabeth N Pavlisko; Victor L Roggli; Nevins W Todd; Rahul G Sangani
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.